CBD also led to a downregulation of the sex-determining region Y (SRY)-Box 2 (Sox-2), a critical determinant of glioma tumour initiating cell growth and downstream target of Id-1, in glioblastoma cells [99]. Here, SOX2 is linked to glioblastoma.